These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21627335)
21. Delivery of esomeprazole magnesium through nasogastric and gastrostomy tubes using an oral liquid vehicle as a suspending agent in vitro. Shah SA; Sander S; Coleman CI; White CM Am J Health Syst Pharm; 2006 Oct; 63(19):1882-7. PubMed ID: 16990636 [TBL] [Abstract][Full Text] [Related]
22. Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity. Hendeles L; Dorf A; Stecenko A; Weinberger M JAMA; 1990 May; 263(18):2459-61. PubMed ID: 2329633 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466 [TBL] [Abstract][Full Text] [Related]
25. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison. Mohylyuk V; Yerkhova A; Katynska M; Sirko V; Patel K AAPS PharmSciTech; 2021 Jun; 22(5):188. PubMed ID: 34159427 [TBL] [Abstract][Full Text] [Related]
26. Creon 10,000 Minimicrospheres vs. Creon 8,000 microspheres--an open randomised crossover preference study. Patchell CJ; Desai M; Weller PH; Macdonald A; Smyth RL; Bush A; Gilbody JS; Duff SA J Cyst Fibros; 2002 Dec; 1(4):287-91. PubMed ID: 15463829 [TBL] [Abstract][Full Text] [Related]
27. Measuring dissolution profiles of single controlled-release drug pellets. Bhakta HC; Lin JM; Grover WH Sci Rep; 2020 Nov; 10(1):19734. PubMed ID: 33184351 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784 [TBL] [Abstract][Full Text] [Related]
29. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. Santini B; Antonelli M; Battistini A; Bertasi S; Collura M; Esposito I; Di Febbraro L; Ferrari R; Ferrero L; Iapichino L; Lucidi V; Manca A; Pisconti CL; Pisi G; Raia V; Romano L; Rosati P; Grazioli I; Melzi G Dig Liver Dis; 2000; 32(5):406-11. PubMed ID: 11030186 [TBL] [Abstract][Full Text] [Related]
30. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537 [TBL] [Abstract][Full Text] [Related]
31. Postcibal gastric emptying of pancreatin pellets: effects of dose and meal oil. Meyer JH; Lake R; Elashoff JD Dig Dis Sci; 2001 Sep; 46(9):1846-52. PubMed ID: 11575435 [TBL] [Abstract][Full Text] [Related]
32. In Vitro Evaluation of Nasogastric Tube Delivery Performance of Esomeprazole Magnesium Delayed-Release Capsules. Hoover A; Sun D; Wen H; Jiang W; Cui M; Jiang X; Keire D; Guo C J Pharm Sci; 2017 Jul; 106(7):1859-1864. PubMed ID: 28416417 [TBL] [Abstract][Full Text] [Related]
33. A comparison of two pancreatin microsphere preparations in cystic fibrosis. Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114 [TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261 [TBL] [Abstract][Full Text] [Related]
36. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of various gastrojejunostomy tube constructs for enteral support of small animal patients. Risselada M; Griffith E; Kapler M; McDonald-Lynch M J Am Vet Med Assoc; 2018 May; 252(10):1239-1246. PubMed ID: 29701521 [TBL] [Abstract][Full Text] [Related]
40. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency. Sander-Struckmeier S; Beckmann K; Janssen-van Solingen G; Pollack P Pancreas; 2013 Aug; 42(6):983-9. PubMed ID: 23587850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]